Dose-dense AC Followed by Dose-Dense Paclitaxel/Trastuzumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of doxorubicin and cyclophosphamide, followed by a dose-dense regimen of paclitaxel, and trastuzumab that may be used in the treatment of breast cancer.
**Synonyms:** - DD Doxorubicin/Cyclophosphamide Followed by DD Paclitaxel Plus Trastuzumab - Dose-dense AC Followed by Dose-Dense Paclitaxel Plus Trastuzumab - Dose-dense AC Followed by Dose-Dense Paclitaxel Plus Trastuzumab Regimen - Dose-dense Adriamycin/Cytoxan Followed by Dose-dense Taxol Plus Herceptin - Dose-dense Doxorubicin/Cyclophosphamide Followed by Dose-dense Paclitaxel Plus Trastuzumab - ddAC-ddTH (Paclitaxel) - ddAC-ddTH (Paclitaxel) (trastuzumab-anns) - ddAC-ddTH (Paclitaxel) (trastuzumab-dkst) - ddAC-ddTH (Paclitaxel) (trastuzumab-dttb) - ddAC-ddTH (Paclitaxel) (trastuzumab-herw) - ddAC-ddTH (Paclitaxel) (trastuzumab-pkrb) - ddAC-ddTH (Paclitaxel) (trastuzumab-qyyp) - ddAC-ddTH (Paclitaxel) (trastuzumab-strf) - ddAC-ddTH (Paclitaxel) (trastuzumab-zerc)
/api/v1/systems/nci_thesaurus/nodes/C191722Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.